Trusted News Discovery Since 2008
{{/content}}
Weight loss drug gets US nod to treat sleep apnea; India launch likely next year
Credit: IndiaTimes- Published 1 hour ago
The US FDA has approved the anti-diabetic drug Zepbound (Tirzepatide) for managing obstructive sleep apnea (OSA) in obese adults. Eli Lilly plans to launch the drug in India by 2025, pending approvals. The treatment is expected to be a breakthrough by aiding weight reduction, which in turn improves breathing during sleep.
You are here
💡 newsR Knowledge: Other News Mentions
Tirzepatide
Anti-diabetic and weight loss medication
Food and Drug Administration
United States federal agency
Eli Lilly and Company
American pharmaceutical company
Related videos from verified sources
Jamie Foxx Gets Stitches After Birthday Dinner Altercation, Jane Seymour Flees Malibu Home Amidst Wildfires, Jelly Roll's 120lb 01:00
Credit: LifeMinute.tv - Published 1 week ago